Wenwu Cheng

1.8k total citations
24 papers, 310 citations indexed

About

Wenwu Cheng is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Wenwu Cheng has authored 24 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Wenwu Cheng's work include Palliative Care and End-of-Life Issues (9 papers), Cancer survivorship and care (5 papers) and Patient Dignity and Privacy (4 papers). Wenwu Cheng is often cited by papers focused on Palliative Care and End-of-Life Issues (9 papers), Cancer survivorship and care (5 papers) and Patient Dignity and Privacy (4 papers). Wenwu Cheng collaborates with scholars based in China, South Korea and United States. Wenwu Cheng's co-authors include Xiaoli Gu, Zhe Zhang, Weiwei Zhao, Minghui Liu, Huixun Jia, Nong Li, Minghui Liu, Peng Wang, Zhe Zhang and Zhenyu Wu and has published in prestigious journals such as Scientific Reports, Oncotarget and Psycho-Oncology.

In The Last Decade

Wenwu Cheng

24 papers receiving 302 citations

Peers

Wenwu Cheng

PHEOH

ONCOL

Temsak Phungrassami Thailand

Wen‐Chi Shen Taiwan

Jessica Ma United States

Vasileios Sioulas Greece

Su Jin Koh South Korea

Shapei Yan United States

Maria Antonietta Orengo Italy

Taketo Mukaiyama Japan

Olive P. Khaliq South Africa

Colleen Lawrence United States

Temsak Phungrassami Thailand

Wenwu Cheng

138 ×0.9

PHEOH

72 ×0.9

ONCOL

61 ×0.9

31 ×0.6

23 ×0.6

Citations per year, relative to Wenwu Cheng Wenwu Cheng (= 1×) peers Temsak Phungrassami

Countries citing papers authored by Wenwu Cheng

Since Specialization

Citations

This map shows the geographic impact of Wenwu Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwu Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwu Cheng more than expected).

Fields of papers citing papers by Wenwu Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwu Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwu Cheng. The network helps show where Wenwu Cheng may publish in the future.

Co-authorship network of co-authors of Wenwu Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenwu Cheng. A scholar is included among the top collaborators of Wenwu Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenwu Cheng. Wenwu Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Ke, Jun Yan, Fuqing Lin, et al.. (2024). Current Status of Cognition and Clinical Practice of Refractory Cancer Pain in Shanghai: A Questionnaire Survey. Journal of Pain Research. Volume 17. 1413–1422. 1 indexed citations

Zhang, Jing, Jiawen Zhang, Weiwei Zhao, Qingxian Li, & Wenwu Cheng. (2023). Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer. Frontiers in Genetics. 13. 1067826–1067826. 7 indexed citations

Zhang, Zhe, et al.. (2021). Chemotherapy and targeted therapy near the end of life affects aggressiveness of palliative care. Annals of Palliative Medicine. 10(3). 2917–2925. 5 indexed citations

Zhang, Zhe, Nong Li, Xiaoli Gu, et al.. (2020). Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals. 35(10). 771–775. 21 indexed citations

Zhang, Zhe, Nong Li, Xiaoli Gu, et al.. (2020). LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212. Cancer Biotherapy and Radiopharmaceuticals. 37(2). 119–124. 8 indexed citations

Zhang, Zhe, et al.. (2020). Use of palliative chemotherapy near the end of life: a retrospective cohort study. Annals of Palliative Medicine. 9(5). 2809–2816. 3 indexed citations

Zhang, Zhe, Nong Li, Xiaoli Gu, et al.. (2020). Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line. Acta Biochimica et Biophysica Sinica. 52(9). 1007–1015. 25 indexed citations

Zhang, Jing, Qingxian Li, Jiawen Zhang, et al.. (2019). C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care. Journal of Palliative Medicine. 22(12). 1536–1545. 12 indexed citations

Zhao, Weiwei, Zhiyong He, Yintao Li, et al.. (2019). Nomogram-based parameters to predict overall survival in a real-world advanced cancer population undergoing palliative care. BMC Palliative Care. 18(1). 47–47. 5 indexed citations

10.

Zhao, Weiwei, Peng Wang, Huixun Jia, et al.. (2017). Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?. BMC Cancer. 17(1). 514–514. 33 indexed citations

11.

Zhao, Weiwei, Peng Wang, Huixun Jia, et al.. (2017). Neutrophil count and percentage: potential independent prognostic indicators for advanced cancer patients in a palliative care setting. Oncotarget. 8(38). 64499–64508. 11 indexed citations

12.

Zhao, Weiwei, Zhenyu Wu, Yintao Li, et al.. (2016). Pretreatment neutrophil-to-lymphocyte ratio and its dynamic changes are associated with the overall survival in advanced cancer patients undergoing palliative care. Scientific Reports. 6(1). 31394–31394. 18 indexed citations

13.

Gu, Xiaoli, et al.. (2016). Management of non-ovarian cancer malignant ascites through indwelling catheter drainage. BMC Palliative Care. 15(1). 44–44. 6 indexed citations

14.

Gu, Xiaoli & Wenwu Cheng. (2016). Chinese oncologists’ knowledge, attitudes and practice towards palliative care and end of life issues. BMC Medical Education. 16(1). 149–149. 22 indexed citations

15.

Gu, Xiaoli, et al.. (2015). Timing of referral to inpatient palliative care services for advanced cancer patients and earlier referral predictors in mainland China. Palliative & Supportive Care. 14(5). 503–509. 13 indexed citations

16.

Gu, Xiaoli, et al.. (2015). End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai, China. Supportive Care in Cancer. 24(5). 2209–2215. 36 indexed citations

17.

Gu, Xiaoli, et al.. (2015). Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China. BMC Palliative Care. 14(1). 5–5. 20 indexed citations

18.

Li, Haitao, et al.. (2015). TWO-DIMENSIONAL X-RAY DIFFRACTION TO INVESTIGATE γ/γ' LATTICE MISFITS IN DIFFERENT PREPARATIONS OF SINGLE-CRYSTAL NICKEL-BASED SUPERALLOY DD483. High Temperature Material Processes An International Quarterly of High-Technology Plasma Processes. 19(3-4). 231–247. 1 indexed citations

19.

Gu, Xiaoli, et al.. (2014). The Preference of Place of Death and its Predictors Among Terminally Ill Patients With Cancer and Their Caregivers in China. American Journal of Hospice and Palliative Medicine®. 32(8). 835–840. 47 indexed citations

20.

Cheng, Wenwu. (2010). Palliative sedation for terminally ill cancer patients. Zhongguo aizheng zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact